List of Excipients in API orphenadrine citrate, aspirin and caffeine
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing orphenadrine citrate, aspirin and caffeine
Detailed excipient profiles for orphenadrine citrate, aspirin and caffeine
Excipient focus: ANHYDROUS LACTOSE
orphenadrine citrate, aspirin and caffeine drug variants containing ANHYDROUS LACTOSE
orphenadrine citrate, aspirin and caffeine drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
orphenadrine citrate, aspirin and caffeine drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | orphenadrine citrate, aspirin and caffeine | 21695-726 |
| Poly Pharmaceuticals Inc | orphenadrine citrate, aspirin and caffeine | 50991-999 |
| >Company | >Ingredient | >NDC |
orphenadrine citrate, aspirin and caffeine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
orphenadrine citrate, aspirin and caffeine drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | orphenadrine citrate, aspirin and caffeine | 21695-726 |
| Poly Pharmaceuticals Inc | orphenadrine citrate, aspirin and caffeine | 50991-999 |
| >Company | >Ingredient | >NDC |
orphenadrine citrate, aspirin and caffeine drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C YELLOW NO. 10
orphenadrine citrate, aspirin and caffeine drug variants containing D&C YELLOW NO. 10
orphenadrine citrate, aspirin and caffeine drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
orphenadrine citrate, aspirin and caffeine drug variants containing FD&C BLUE NO. 1
orphenadrine citrate, aspirin and caffeine drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
orphenadrine citrate, aspirin and caffeine drug variants containing POVIDONE
orphenadrine citrate, aspirin and caffeine drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
orphenadrine citrate, aspirin and caffeine drug variants containing SILICON DIOXIDE
orphenadrine citrate, aspirin and caffeine drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
orphenadrine citrate, aspirin and caffeine drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | orphenadrine citrate, aspirin and caffeine | 21695-726 |
| Poly Pharmaceuticals Inc | orphenadrine citrate, aspirin and caffeine | 50991-999 |
| >Company | >Ingredient | >NDC |
orphenadrine citrate, aspirin and caffeine drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
orphenadrine citrate, aspirin and caffeine drug variants containing STARCH, CORN
orphenadrine citrate, aspirin and caffeine drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
orphenadrine citrate, aspirin and caffeine drug variants containing STEARIC ACID
orphenadrine citrate, aspirin and caffeine drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
orphenadrine citrate, aspirin and caffeine drug variants containing WATER
orphenadrine citrate, aspirin and caffeine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | orphenadrine citrate, aspirin and caffeine | 21695-726 |
| Poly Pharmaceuticals Inc | orphenadrine citrate, aspirin and caffeine | 50991-999 |
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC STEARATE
orphenadrine citrate, aspirin and caffeine drug variants containing ZINC STEARATE
orphenadrine citrate, aspirin and caffeine drug variants not containing ZINC STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | orphenadrine citrate, aspirin and caffeine | 21695-726 |
| Poly Pharmaceuticals Inc | orphenadrine citrate, aspirin and caffeine | 50991-999 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
